CD9 and breast carcinoma: In fact, there have been reports indicating that the administration of antibodies targeting CD9, which is expressed on the membrane of EVs, to xenograft model mice of breast cancer resulted in the active removal of CD9 antibody-bound EVs by macrophages, consequently leading to the inhibition of lung metastasis (Nishida-Aoki et al., 2017).